Record $6.0M Quarter, First Time Revenue Tops Cash Burn; $150M Shelf Filed
HYPR is trading near its 52-week low of $0.667 (5.9% above the low).
Summary
Hyperfine posted record Q3 2026 revenue of $6.0 million, up 73% year-over-year and 53% sequentially, with gross margin at a record 57% and 14 commercial Swoop systems sold versus 8 a year ago. Net loss narrowed to $6.0 million ($0.06 per share) from $11.0 million ($0.14) a year earlier, and net cash burn fell to $5.6 million — the first quarter revenue exceeded cash burn. Cash stood at $37.9 million on September 30 with no financing proceeds raised in the quarter, and management reiterated full-year 2026 revenue of $20-22 million and net cash burn of $26-28 million. The company also flagged a new $150 million universal shelf registration, including a $50 million at-the-market program, to replace the existing shelf expiring this month. That shelf matters most for a sub-$1 stock already under a September 17 Nasdaq delisting notice after 30 straight closes below $1.00 — the operating improvement is real, but the listing issue and potential dilution remain the swing factors. FDA submission for expanded Swoop labeling from the completed Contrast PMR study is expected by end of 2026.
At the time of this announcement, HYPR was trading at $0.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $75M. The 52-week trading range was $0.67 to $1.94. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.